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ABSTRACT 
Patient-reported data, specifically patient-reported outcomes (PRO) measurement, has 
grown in relevance to patient-centeredness in healthcare delivery as well as in clinical 
outcomes research. Nonetheless, the uptake of PRO measurement tools, although 
many have been validated and approved for use in research settings, has been slow on 
the part of clinical outcomes researchers due to their preference for more objective, 
performance-based outcomes measurement. Consequently, there is a need for 
confirming the value of PROs in patient-centered research and assessing the role 
dynamic of PROs versus performance-based tests in outcomes research. In an effort to 
fill investigators’ knowledge gap in this area, the following secondary data analysis, 
conducted upon baseline and follow-up data from the 2011 Walk With Ease program (a 
community walking program for arthritis patients), evaluated the validity and value of 
PRO measures as compared to performance-based measures of physical functioning. 
Primary results found that patient-reported and performance-based measures were 
poorly correlated with one another, indicating that they measure physical function 
differently from one another. Furthermore, both measures detected significant changes 
in physical functioning over time, indicating that they may be equivalently effective in 
assessing an intervention centered on improving physical functioning. Finally, the 
patient-reported measures were more strongly inversely correlated with other key 
arthritis symptoms than performance-based measures, meaning they may have been 
more effective in measuring physical function in the context of arthritis. There findings 
will ideally provide an impetus for researchers to recognize the validity and value-added 
of patient-reported data and incorporate it more widely into outcomes research. 
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INTRODUCTION 
The mid-1970s onwards saw an emergence of the use of patient-reported data to inform 
decision-making in a number of settings, including healthcare delivery, clinical research, 
and health policy.  Patient-reported outcomes (PROs), or directly communicated 
information from patients about health conditions, grew out of the burgeoning movement 
towards incorporating a patient-centered focus into healthcare and clinical research. A 
growing evidence base indicates that patients who are more actively engaged in their 
healthcare choose higher-value healthcare services and experience higher-quality 
outcomes—improving the quality of healthcare overall.1,2 Accompanying this growth in 
evidence is the industry-wide recognition that patients are the ultimate recipients of care 
and thus, the most influential decision-makers regarding their care. Therefore, patient 
reports emerged as a valuable mechanism to measure, interpret, and enhance the 
quality of care. PROs center mostly on the area of global or holistic health-related 
quality of life (HRQOL), but can also be specific to certain disease areas or symptoms.3 
 PROs play an important role in assessing the physical function of individuals with 
arthritis.  Functional disability, or the relative inability to perform activities of daily living 
(ADL) and instrumental activities of daily living (IADL), is one of the most damaging and 
pervasive effects of arthritis. However, individual abilities to perform ADLs and IADLs 
are influenced by a multitude of overlapping physiological and environmental factors, 
making it difficult to measure how physically functional patients are in reality. For this 
reason, researchers have found that patient self-reports are useful in measuring 
physical function in arthritis patients from the perspective of the patients themselves. 4  
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PRO measurement instruments have historically posed barriers on performance 
measurement because of the methodological difficulty in administering the instruments 
and ensuring that they meet appropriate psychometric standards in terms of reliability 
and validity.5 Moreover, researchers continue to speculate that PROs lack validity 
because of the subjective nature of patient self-reports and imprecision of existing PRO 
measurement tools.6,7 Healthcare providers have also raised questions as to whether a 
patient self-report is as valid as the current “gold standard” method-- performance-
based (“objective”) tests, such as a “sit test” to measure lower extremity mobility. Thus, 
in recent years, PRO research has aimed to develop statistically and clinically superior 
measurement tools that may act as a new gold standard in assessing patient 
experiences. An important part of validating these new tools is to compare them to the 
performance-based tests that are already widely in use. 
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REVIEW OF ACADEMIC LITERATURE 
Measuring HRQOL and patient satisfaction with care has grown to become a key 
consideration in at least two areas: quality of care improvement and clinical research. 
Significant healthcare quality improvement efforts in the United States originated 
subsequent to Avedis Donabedian’s pivotal 1966 publication “Evaluating the Quality of 
Medical Care”, which introduced the ‘structure-process-outcomes’ model for measuring 
the quality of care.8 However, it was not until the Institute of Medicine (IOM) released 
the “Crossing the Quality Chasm” report in 2001 that the systemic importance of the 
quality of healthcare shot to the forefront of the national healthcare agenda and 
encouraged government and industry investment in quality improvement initiatives.9  
In spite of the IOM report’s emphasis on “patient-centeredness” as one of its key 
“aims for improvement” of quality in the publication, the health care delivery setting 
continues to be biased towards the usage of objective measures of quality, rather than 
subjective, patient-centered measures, to determine gaps in care. The Patient 
Protection and Affordable Care Act of 2010 mandated the creation of a National Quality 
Strategy to reemphasize the aims of health care quality improvement and to reestablish 
six key priority areas in moving towards a high-value health system. One of the key 
components of this six-pronged approach is “person- and family-centered care”, which 
acknowledges the importance of recognizing patients as the ultimate decision-makers in 
their care.10  
The movement towards patient-centeredness and engagement has also found 
promise over the past two decades within the rapidly growing area of HRQOL research.  
Traditionally, clinical trials measure survival or disease response. For example, 
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scientists conducting cancer trials continue to acknowledge “survival” and “disease-free 
survival” as the main end points of cancer therapy, and frequently raise questions about 
the value of PROs in cancer drug research.14 However, the movement towards patient-
centered research has emphasized the need to look at patients as a whole. This 
emphasis requires the need to observe how a disease and its treatment may impact the 
lives of individuals with that disease and their caregivers.  HRQOL examines how 
therapy affects a person’s life physically, mentally, and socially. Specifically, it covers 
five categories that include duration of life, impairments, functional status, health 
perceptions, and opportunities.15 Additionally, measurement of HRQOL may be 
particularly useful in clinical trials, where improvements in medical care and technology 
have led to advanced laboratory or clinical tests whose results may not be universally 
applicable to patients in a variety of circumstances. Many trials have also found that two 
different treatments may have a similar impact on survival or another clinical end point, 
but display adverse effects (for example, fatigue or nausea) that affect activities of daily 
living or other aspects of patient quality of life16. Thus, many clinical trials now include 
HRQOL measures as secondary endpoints and some trials use symptom response as 
the primary endpoint.17 
Since domains of HRQOL and satisfaction with care are subjective in nature, 
scholars recognize that patient reports, as a more organized method of communication, 
are the gold standard for self-reporting individual experiences and perspectives. Patient-
Reported Outcomes (PROs) are “any report of the status of a patient’s (or person’s) 
health condition, health behavior, or experience with healthcare that comes directly from 
the patient, without interpretation of the patient’s response by a clinician or anyone 
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else”.18 PRO measures are the instruments or questionnaires used to assess PROs in a 
systematic, reliable, and valid way. PRO measures have been an essential component 
of the assessment of patients with arthritis, specifically rheumatoid arthritis (RA), for 
almost two decades. A long-term cure for RA does not currently exist; thus, treatment of 
RA must focus profoundly on relieving pain and other disabling effects and improving 
patients’ ability to perform activities of daily living20. A seminal 1996 publication in the 
British Journal of Rheumatology described the need for a measure to identify and 
quantify the ‘disability impact’ of RA, which emphasized the highly subjective nature of 
arthritis symptoms and outcomes. Little research has been done, however, to observe 
whether these types of measures correspond with clinically observed performance-
based test results or clinician-reported measures.20,21 Although considerable research 
has been done in the realm of PRO measures within the past few decades, greater 
room for exploration still exists within best practices for developing and administering 
PRO measures in clinical research and healthcare delivery settings.13 
In subsequent years, new PRO measures began to emerge such as the Medical 
Outcome Study Short Form-36 (SF-36) and the Health Assessment Questionnaire 
(HAQ). However, many of these questionnaires were either broad and imprecise, or 
precise but limited to a narrow range of measurement.22,23 These systems became 
widespread to the extent that PROs were being used more frequently in quality 
improvement initiatives and clinical research, but there remained room for improvement 
regarding the validity of the PRO measures, as they had the potential to favor 
practicality (due to the concise nature of their short forms and their relative ease of 
administration) over accurate precise measurement of PROs.21 Consequently, as part of 
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the National Institutes of Health’s Roadmap for Medical Research initiative, the 
PROMIS (Patient-Reported Outcomes Measurement Information System) HAQ 
(henceforth referred to as PROMIS), deriving from the original HAQ, was introduced in 
2004 as a superior tool that could be used “across a wide variety of chronic diseases 
and conditions and in the general population”.24 PROMIS incorporates computerized 
adaptive testing (CAT) and short-form patient questionnaires in the domains of physical 
health, mental health and social health. PROMIS is based on item response theory 
(IRT), which allows the PROMIS CAT to individually tailor assessments to patients 
according to previous responses. This allows for a dynamic outcomes measurement 
experience and results in precise and briefer measurement than traditional static forms 
used by existing PRO measures.23 
PROMIS is still undergoing psychometric validation assessments. However, from 
the clinical trial and quality of care perspectives, the rapid integration of PROMIS into 
clinical outcomes research presents the possibility of savings in research costs. The 
streamlined survey framework and CAT format of PROMIS presents the possibility of 
enhanced efficiency of clinical outcomes research. Researchers can potentially cut 
costs significantly in administering the questionnaire to patients, as it only asks the 
questions that are most relevant to patients and omits those questions that are 
imprecise, redundant, or irrelevant.24 Furthermore, more precise PROMIS measures 
allow for smaller sample sizes in trials (fewer enrolled subjects) while retaining the same 
amount of statistical power of the trial; when the PRO is the primary endpoint.25  
PROMIS publications over the past 8 years have focused on demonstrating the 
reliability and validity of the measures in populations diverse in socio-demograph
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clinical characteristics. The "Walk With Ease" (WWE) Program, a 6 week-long 
community-based walking program for groups of adults with arthritis, was established 
about ten years ago by the Arthritis Foundation. It was designed to incorporate regular, 
medium-intensity physical activity into arthritis treatment, as this type of activity has 
been shown to relieve pain, fatigue, and joint stiffness among arthritis patients.22 The 
program was modified in 2006 to be amenable to a self-directed format as well as the 
original group format. A 2011 study conducted by Callahan, et al. evaluated the two 
program formats. The study enrolled a total of 426 WWE study participants and 
assessed physical function (performance-based and self-reported) as well as other 
arthritis symptoms (pain, fatigue) at baseline and after 6 weeks. Performance-based 
measurements were taken by administering clinical observational tests, such as timed 
chair stands to assess lower extremity strength and walking speed tests to assess 
mobility. Additionally, the researchers measured patient-reported physical function with 
PRO measures including PROMIS and HAQ.28  
This study followed up on the results of the aforementioned study and used a 
secondary data analysis to assess the association between patient-reported and 
performance-based measures of physical function. It specifically assessed the 
relationship between patient-reported measures (i.e.,PROMIS and HAQ) and 
performance-based measures (e.g. timed chair sits, 6-minute walk tests) of physical 
functioning. The study was broken down into the following research aims: 
AIM 1. Evaluate the association between performance-based (PB) measures and PRO 
measures of physical function (PF) 
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AIM 2. Evaluate differences between the PB measures and the PRO measures in 
measuring change in PF between the instructor-led arm of the trial and the self-
directed arm of the trial. 
AIM 3. Evaluate the differences between the PB measures and the PRO measures of 
PF as they relate to other key patient-centered outcomes including pain, fatigue, and 
stiffness. 
 
METHODS 
Participants/Sample 
This study was a secondary data analysis on the results of the Arthritis Foundation’s 
Walk With Ease (WWE) study. The WWE study recruited participants who self-reported 
joint pain, stiffness, or any type of physician-diagnosed arthritis. The participants were 
also required to be at least 18 years old, able to speak English, cognitively intact, and 
without a serious medical condition in order to be eligible to participate in the study. 
After recruitment efforts, 462 participants were enrolled into the study. Of these 
participants, 415 participants completed PROMIS Physical Functioning measures via 
Computerized Adaptive Testing (CAT).  
 
Study Design 
The WWE study aimed to evaluate the effectiveness of revisions to the WWE program, 
namely the incorporation of a self-directed option in addition to an instructor-led group 
option. Subsequent to being enrolled in the study, the participants were able to self 
select the study arm to which they preferred to belong--either the instructor-led group 
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format or the self-directed format--for the duration of the 6 week WWE program. The 
Instructor-led group participants were directed through the 6 week program by an 
instructor and met three times a week for one hour, while the self-directed participants 
did not have an instructor and used the WWE workbook to guide themselves through 
the program. The group instructors were WWE leaders who were recruited from fitness 
centers and senior centers, and trained using the Arthritis Foundation WWE Leader 
Training Guide. 
The participants completed patient-reports and performance-based tests of 
physical function at baseline and at completion of the six-week walking program. Group 
and self-directed participants completed baseline assessments at various community 
locations one week before the group classes began. Participants completed an 
electronic or a paper-based self-report questionnaire, as well as a set of performance-
based tests. Baseline assessments took place from June through September 2008. The 
participants completed follow up assessments at each site at six weeks after 
commencing the program. Assessments were conducted from August to November 
2008. The assessments consisted of performance-based tests of physical function, 
patient-reported questionnaires, and a written satisfaction survey regarding their 
experience in the WWE program. 
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Outcomes Measures 
Table 1 below summarizes the outcomes measures used in this study and the metrics 
according to which they were measured. 
 
Table 1. Outcomes measures classified by type of measurement. 
Measure Metric Function 
Performance-Based Physical Function Measures 
3 Chair Stands: to stand 
up and sit back down in 
an armless chair three 
times in succession 
Time in seconds for one 
trial 
Assess lower extremity 
strength 
Turn Tests: stand with 
arms at the side and feet 
comfortably apart and 
turn in a full circle to the 
right and then the left. 
Average time in seconds for 
two trials in each direction 
Assess turning ability and 
balance 
Single leg Stance: stand 
next to wall or raised 
surface and stand one 
leg, then the other while 
placing arms across 
chest 
Number of seconds of 
balance (maximum of 30) 
for one trial on each leg 
Assess balance 
Walking Speed: walk a 
20- foot distance on flat 
ground at both a normal 
and a fast walking pace. 
Average time in seconds to 
complete the distance for 
two trials at each pace 
Assess functional mobility 
2- minute step test: 
march in place for two 
minutes, taking as many 
steps as possible and 
raising both knees to a 
pre-determined height. 
Number of steps completed 
in one trial 
Assess aerobic endurance 
Primary Patient-Reported Physical Function Measures 
PROMIS – Physical 
Functioning 
Each item ranked from 5-1 
with higher score 
representing higher 
physical functioning; 
adjusted final score from 0-
100 
Assess all aspects of 
physical function 
Health Assessment 
Questionnaire (HAQ) 
Each item ranked from 1-5 
with higher score 
Assess all aspects of 
physical function 
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representing lesser physical 
functioning; adjusted final 
score from 0-60 
Secondary Patient Self-Reported Measures 
Visual Analog Scale 
(VAS—
Pain/Stiffness/Fatigue 
Mm from beginning of 100 
mm line 
Assess arthritis symptoms 
 
Primary Outcome: The primary outcomes measure for the participants in this study was 
physical function, which was measured by way of patient-reported and performance-
based measures. 
Performance-Based Tests: Eight physical performance-based tests were 
conducted to observe the physical functioning of each participant. The tests were 
completed on the same day as the patient-reported measures. 
 
PROMIS - Physical Function: The electronic self-reported questionnaires were 
administered using the National Institutes of Health PROMIS (Patient-Reported 
Outcomes Measurement Information System) Computerized Adaptive Testing 
(CAT) instrument to measure Physical Function. Data from the instrument were 
captured in the PROMIS Assessment Center, a secure online research 
management server. The PROMIS electronic questionnaire uses Item Response 
Theory (IRT) to measure aspects of Health-Related Quality of Life (HRQOL)—in 
this case, Physical Function. Items are selected for each participant based on the 
participant's responses to previously administered items. The IRT-based test 
uses an algorithm to “estimate a person's score and the score's reliability and 
then chooses the best next item”.24 All the items/questions ask to report on 
abilities to complete certain physical activities that exert the upper body (eg 
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dressing yourself, washing back), middle trunk (sitting on bed), and lower body 
(walking, running). 
On average, participants completed approximately 5 questions in 
PROMIS, where each question was tailored to their specific physical functioning 
ability.  They rated the difficulty with which they are able to complete each 
physical activity described in the items using two 5-option response scales. 
Based on the type of question posed, the response scales are ranked either from 
“without any difficulty” to “unable to do”, or “not at all” to “cannot do”. The item 
responses are scored 1-5 such that a higher score represents higher physical 
functioning. Item scores are adjusted for assistance by people or devices, 
averaged, and multiplied by 25 to give the total score on a scale of 0-100. 
 
HAQ: The disability scale of the Stanford Health Assessment Questionnaire 
(HAQ-DI) assesses self-report function.  The HAQ consists of 20 questions.  It 
differs from the PROMIS questionnaire in terms of not being adaptive and having 
a 4-option response scale for each of the items as opposed to 5 options. Though 
the HAQ-DI response scale still ranges from “without any difficulty” to “unable to 
do”, The PROMIS scale incorporates the option of choosing “with a little difficulty” 
in one of its response scales. Furthermore, the HAQ response scale options are 
ranked from 0-3 by increasing difficulty, while the PROMIS response scale 
options are ranked 5-1 by decreasing difficulty. Therefore, an increase in the 
HAQ score would represent a greater degree of disability in physical functioning, 
while an increase in the PROMIS score would represent a lesser degree of 
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disability in physical functioning. The final HAQ scores, ranging from 0-60, are 
obtained by adding up the scores from individual items. 
 
Secondary Outcome: the main secondary outcome measures were arthritis symptoms, 
namely pain, stiffness, and fatigue. 
 
Visual Analog Scale (VAS): The self-report measure used to measure arthritis 
symptoms was the VAS. For pain, participants completed the measure by 
marking their pain experience over the last 7 days on a 100 mm line that ranged 
from “no pain” to “pain as bad as it could be”. Stiffness and fatigue were 
measured similarly. Higher VAS scores indicated a greater degree of fatigue, 
pain, and stiffness. 
 
Covariates  
Information regarding gender, age, race, education, and BMI were self-reported. 
Gender was reported as male or female. Actual age was measured as a continuous 
variable, and standard deviation and range were also reported. Race was also stratified 
into three levels: Caucasian, African-American, or other. Education was dichotomized 
as greater than high school or less than high school. BMI was calculated by self-
reported height and weight and reported in kg/m2, and was stratified into two levels: less 
than 30 and greater than or equal to 30.  
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Statistical Analysis 
All analyses will be conducted using STATA 13. 
 
AIM 1. Evaluate the association between performance-based (PB) measures and PRO 
measures of physical function. 
Aim 1 attempts to answer the question of whether patient-reported outcomes 
(PRO) measures, HAQ and PROMIS, and performance-based (PB) measures 
are measuring the same aspects of a specific endpoint-- in this case, physical 
functioning. The hypothesis was that both methods of measurement are 
assessing different aspects of physical function respectively, predicting a fair to 
moderate degree of correlation between the two types of measures. In order to 
test this hypothesis, the study calculated Spearman’s rank correlation coefficients 
between the participants’ scores of each of the PRO measures and each of the 
PB measures at baseline and at six week follow-up (subsequent to the WWE 
intervention).  The Spearman’s correlation method will be used rather than 
Pearson correlations as the physical function scores cannot be assumed to be 
continuous or normally distributed.. The correlation coefficients will be reported 
and the strength of the correlations will be classified according to Table 2 below. 
Table 2. Qualitative classification of correlation strength 
R-Value  Strength of Spearman’s Correlation 
< 0.3 Poor 
0.3 ≤ X < 0.5 Fair 
0.5 ≤ X <0.8 Moderate 
≥ 0.8 Strong 
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AIM 2. Evaluate differences between the performance-based measures and the PRO 
measures in measuring change in physical functioning between the Instructor-led 
(Group) arm of the trial and the Self-directed (independent) arm of the trial. 
 Aim 2 attempts to answer the question of whether or not the PRO measures and 
the PB measures measure the same aspects of physical function within the context of 
evaluating the effectiveness of the two interventions over the two time points. In 
alignment with the hypothesis of Aim 1, which predicted that the PRO and PB measures 
each measure different aspects of physical function, the Aim 2 hypothesis consequently 
predicts that there will be different findings for the effectiveness of the interventions 
when using either the PRO or PB measures of physical functioning.  
 In order to answer this question, baseline and follow-up WWE program scores 
were analyzed in two different ways-- within each study arm and for the study overall: 
1. Significance of Score Differences within each Study Arm: two-sample t-tests 
were conducted between baseline and follow-up scores for all physical function 
measures. Two separate sets of t-test were conducted-- one set consisting of 
tests between baseline and follow-up scores in Arm 1 of the study, and another 
for the same scores in Arm 2. These tests assessed the significance of the 
differences in scores between baseline and follow-up within each arm of the 
study to compare the number of significant differences over time between each 
of the study arms and between each type of physical function measure.  
2. Significance of Differences in Score Differences: An additional set of two-sample 
t-tests was conducted for the difference in scores for physical function measures 
between baseline and follow-up comparing the study arms. This analysis 
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observed whether the score differences themselves were significantly different 
for each of the physical function measures between each intervention arm of the 
study.  
Figure 1. Statistical Analysis Framework for Aim 2 
 
AIM 3. Evaluate the differences between the PB measures and the PRO measures of 
PF as they relate to other key patient-centered outcomes including pain, fatigue, and 
stiffness. 
Aim 3 delves into the convergence of PRO and PB measures of physical function 
with other measures of key arthritis outcomes. In particular, past studies have found that 
pain, fatigue, and stiffness are highly negatively correlated with physical function in 
persons suffering from arthritis and other deteriorative joint and muscle diseases.26,27 
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Furthermore, these outcomes are extremely subjective and are difficult to measure in a 
standardized, objective manner. Consequently, the hypothesis for this aim predicted 
that the PRO measures would have higher magnitudes of correlations (i.e. more 
negative correlations) with pain, fatigue and stiffness as compared to the PB measures 
due to the incorporation of subjective patient self-reports in PROs. Spearman’s 
correlation coefficients were calculated at baseline and follow-up among all the scores 
from the physical function measures and the scores from Visual Analog Scale (VAS), 
the PRO measure of pain, fatigue, and stiffness. 
The correlation coefficients will be calculated with reference to: 
1. Comparing the PB measure of PF with pain, fatigue, and stiffness 
2. Comparing PRO measures of PF with pain, fatigue and stiffness 
The strength of the correlation coefficients will be classified according to Table 2 above. 
 
Limitations 
The Walk With Ease study is unique in that it incorporated participant preference for 
instructor-directed versus self-directed walking programs, and allowed for participants to 
self-select the Group or Independent groups (Arm 1 or Arm 2). However, this format, in 
comparison with traditional randomized controlled trials, poses a rather formidable 
limitation for statistical analysis, particularly in reference to Aim 2 of this study. The 
authors of the study allowing for participants to self-select which arm of the study they 
would like to participate in has the potential to affect outcomes from baseline to follow-
up, as an individual who willingly chose the self-directed arm may work harder to 
improve physical function as compared to someone who was randomly assigned to this 
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group. Consequently, this will affect the way the physical function measures assess this 
change in outcomes. 
Additionally, this study inherently assumes that the performance-based (PB) 
tests are the “gold standard” in the measurement of physical function. However, it may 
be possible that other types of performance-based tests may be more appropriate to 
assess physical function among arthritis patients in particular. Furthermore, the results 
of this study may yield some insight into the future use of PRO versus PB tests for 
arthritis patients of a certain age in rural and urban areas of North Carolina, but may not 
be widely generalizable across medical conditions (such as diabetes or cancer) or 
geographic locations outside of the state of North Carolina. 
Lastly, the self-report (PRO) measures examined in this study are unlike the PB 
measures in that they consolidate all three parts of the human body into one measure. 
That is, the questions in the PROMIS questionnaire, for example, are not specific to 
physical function in the upper, middle, or lower trunks of the body. In contrast, the PB 
measures assess different types of physical function in different areas of the body; for 
example, the “Timed Chair Stand” tests assesses only lower extremity strength (Table 
1). Consequently, there may exist discrepancies related to the fact that, if the PRO 
questionnaires were broken up to be specific to the three aforementioned anatomical 
areas of the body, participants may achieve better or worse scores or performance than 
compared to individual performance based measures (that correspond to three 
individual areas of body). 
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RESULTS 
Demographic Characteristics 
The baseline demographic characteristics for the participants enrolled in the Walk With 
Ease (WWE) Program are summarized in Table 1 (Appendix A). A total of 462 
participants were enrolled into the study at baseline. The majority of participants 
(N=270, 58.4%) selected Arm 2 of the study (the Independent, or self-directed arm), 
while the remaining participants (N=192, 41.6%) selected Arm 1 of the study (the 
Group, or instructor-led arm). Participant demographic data showed that the average 
age of an individual enrolled in the study was 70 years, and the average BMI was 29.7. 
Most participants were female overall and within both arms of the study: Arm 1 (N=164, 
85.4%) and Arm 2 (N=242, 89.6%) The majority of participants were married (N=240, 
51.9%), had beyond a high school education (N=336, 72.7%), and were White (N=325, 
70.3%).  
Of note in this data is that Arm 1 participants were on average 6 years older than 
Arm 2 participants, perhaps indicating that older participants more often wished to be in 
a group environment versus an independent environment. Additionally widowed 
participants may have been more likely to choose the Group arm of the study for the 
same reasons, as evidenced by the fact that 31.3% participants who selected Arm 1 of 
the study versus only 16.7% of Arm 2 participants were widowed. 
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Aim 1 Results 
 Aim 1 analysis results are summarized in Table 2 (Appendix B). 
In accordance with the knowledge that a higher HAQ score represents a lower degree 
of physical functioning, most of the correlations between HAQ scores and PB measure 
scores exhibited negative associations. Furthermore, the correlations between PROMIS 
scores and PB measure scores were aligned with the fact that a higher PROMIS score 
represents higher degree of physical functioning, The exceptions to this pattern were 
the baseline and follow-up score correlations between the PB tests ‘3-Chair Stands’, 
‘Turn Right’, and ‘Turn Left’, all three of which exhibited positive correlations with HAQ 
and negative correlations with PROMIS. An explanation for this occurrence is likely 
related to the fact that all three of these tests use the metric of time to assess physical 
function or mobility. For example, ‘Turn Right’ measures the amount of time in seconds 
that it takes the participants to turn 360° to the right. Participants who required less time 
to complete the assigned task for each PB test, whether at baseline or at follow-up, 
likely had a higher degree of physical functioning than their counterparts who took a 
longer time and consequently have lower scores for each test. Because HAQ scores 
also exhibit an inverse relationship with physical functioning, the correlations between 
the three aforementioned PB test scores and HAQ scores have a net positive 
association. 
 The magnitudes of correlations, reported in Table 2, ranged from 0.2125 to 
0.4673 at baseline and 0.2737 to 0.4599 at follow-up. The overall range of correlations 
can thus be qualitatively classified as “Poor” to “Fair, as the values fall below 0.3 and 
between 0.3 and 0.5. Interesting to note is that the correlations between HAQ and 
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PROMIS were -0.7198 and -0.7364 at baseline and follow-up respectively, indicating a 
“Moderate” to “Strong” correlation. This result is not unexpected given the knowledge 
that HAQ and PROMIS are both considered the “gold standard” in PRO measure 
scales; as such, one would anticipate a high degree of association between the two 
tests in their ability to measure physical function. The absolute value of the average 
correlation between HAQ and the PB tests was 0.3267 at baseline and 0.3176 at follow-
up. The average correlations between PROMIS and the PB tests were slightly higher, 
with absolute values of 0.3639 at baseline and 0.3879 at follow-up. Both the correlations 
of the highest magnitude (-0.4327 at baseline and -0.4311 at follow-up) were between 
the average PROMIS score and the average ‘3 Chair Stands’ score. 
 
Aim 2 Results 
The results of the first t-test analysis for Aim 2 are summarized in Table 3 and 4 
(Appendix C), and the results of the second analysis are summarized in Table 5 
(Appendix D). 
 Tables 3 and 4 report the two-tailed and one-tailed significance for each physical 
function measure within each study arm. The first two t-test analyses found 8 significant 
differences in Arm 1 and 9 significant differences in Arm 2 when interpreted in terms of 
two-tailed significance, indicating that the measures may have been slightly more 
effective at measuring physical function in Arm 2, or the in the independent setting. 
However, when the alternative hypothesis was defined as the Ha: diff > 0 (the difference 
in scores is greater than zero), meaning that the follow-up score for each measure was 
significantly greater than the baseline score, there were 3 significant differences in both 
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Arm 1 and Arm 2. The measures for which the alternative hypothesis was defined as 
such were ‘PROMIS score’ (PRO), ‘Single Leg Stance - Right’, ‘Single Leg Stance - 
Left’, and ‘Two-Minute Step Test’, as these measures are defined by metrics that one 
would expect to increase as physical function increases as a result of the WWE 
program. For example, ‘Two-Minute Step Test’ assesses the number of steps that a 
participant can take in 2 minutes of marching in place. The remaining measures’ score 
differences were tested for significance based on the one-tailed alternative hypothesis 
Ha: diff < 0 (meaning that the follow-up score is significantly less than the baseline 
score) because they are defined by metrics that are expected to decrease with greater 
physical function, such as the ‘Normal Walk’ test which measures the number of time in 
seconds that a participants takes to walk a 20-foot distance at a normal walking pace. 
For these tests, 6 significant differences were found for each study arm. 
 Furthermore, the results found that, in Arm 1, both of the PRO measure scores 
exhibited significant differences over time and the majority (6 out of 8) of total PB 
measures had significant differences in scores when observing two-tailed significance. 
Similarly, Arm 2 results saw 2 significant score differences in both of the PRO measures 
again, and 7 significant differences out of the 8 total PB measure score differences.  
 The analysis found further that the difference in scores for the ‘Two Minute Step 
Test’ was significant neither at the two-tailed nor at the one-tailed level, raising the 
question of whether the test was effective in measuring its respective aspect of physical 
functioning (in this case, aerobic endurance) in either intervention arm of the study. 
 The first set of t-tests found that 100% of the PRO measures exhibited significant 
differences for both study arms and 75% and 88% of the PB measures exhibited 
 27 
significant differences for Arm 1 and Arm 2 respectively. However, the results of the 
second set of two-tailed t-tests found there were no significant differences in score 
differences among any of the measures, whether PRO or PB.  
 
Aim 3 Results 
Aim 3 analysis results are summarized in Table 6 (Appendix E). 
 The signs of the Spearman’s correlations displayed in Table 6 exhibit a pattern 
consistent with the earlier remarks about the relationships among the different physical 
function measures and key arthritis outcomes measures—for example, PROMIS is 
negatively correlated with pain, fatigue, and stiffness because as these arthritis 
outcomes increase in magnitude, the PROMIS physical function score would 
presumably decrease in magnitude, exhibiting an inverse relationship. The average 
correlation between HAQ and VAS (reported as absolute value) was 0.4087 at baseline 
and 0.3259 at follow-up, while the average baseline and follow-up correlations between 
PROMIS and VAS were 0.3439 and 0.3327 respectively. These values fall into the 
classification of “moderate” correlation. 100% of the correlations between each of the 
VAS measures and the PRO measures of physical function were statistically significant 
at a significance level of 0.05. The average correlations between VAS and the PB 
measures were significantly lower than the aforementioned correlations with the PRO 
measures: 0.0239 at baseline and 0.0339 at follow-up—these correlations can be 
classified as “poor”. Furthermore, only 27 of the 48 correlations (56.3%) between the 
VAS measures and the PB measures of physical function were significant. 
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 The results showed that VAS– Stiffness scores had the lowest of correlations 
with both HAQ and PROMIS at baseline and at follow-up compared to the other VAS 
measures of key arthritis outcomes. Correspondingly, the VAS-- Pain scores had the 
highest correlations with HAQ and PROMIS of the three key arthritis outcomes 
measures. The only exception to this pattern occurred in the baseline correlations 
between VAS and PROMIS, wherein the highest correlation (-0.3667) was actually 
between VAS—Stiffness and PROMIS while the lowest correlation (-0.3233) was 
between VAS—Fatigue and PROMIS. 
 
DISCUSSION 
In exploring the convergence between PRO and PB measurement tools, the study aims 
answered three broader questions that have greater implications on the future use of 
PRO measures: 
• Do patient-reported measures and performance-based measures of physical 
function measure the same or different aspects of physical functioning? 
The Spearman’s correlations calculated for Aim 1 of this study were “poor” to “fair”, 
supporting the original hypothesis that predicted a “fair” to “moderate” degree of 
correlation between the PRO measures, PROMIS and HAQ, and the PB measures of 
physical functioning. Thus, it can be reasonably stated that, although both types of 
measures are intended to measure the physical function of an individual, perhaps each 
measure assesses different facets of physical function. This is consistent with the 
information from my Limitations section that mentions that, when isolated, each 
performance-based measure only provides information about physical function through 
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particular skill or part of the body. For example, the ‘3 Chair Stands’ test, which times 
the number of seconds it takes participants sit up and back down in an armless chair, 
assesses lower extremity strength in particular. This paints a fragmented picture of 
overall physical function, while the PRO measures, administered in their comprehensive 
survey form, consolidate all parts of the body and skills that contribute to physical 
function and consequently provide a more holistic view of an individual’s physical 
functioning ability. This disconnect in the way each type of measurement scale 
measures physical function likely contributes to the low degree of correlation between 
the two types of measures.  
 However, the data collection stage of the study also presents ample opportunity 
for error on the part of participants and researchers that may have also contributed to 
lower correlations. For example, the PRO measure scores are ultimately patient-
reported data, meaning that the possibility of misunderstanding the questions asked in 
the survey or biases when reporting answers to questions is high, especially among an 
older population. Moreover, there is always a certain degree of subjectivity involved in 
“objective” performance-based measures, meaning that the researchers measuring the 
outcomes of the PB tests could have possibly misjudged the number of seconds or the 
number of steps that a participant took to complete a certain task within each test. 
 
• Do patient-reported measures and performance-based measures respond 
equivalently when evaluating the effectiveness of an intervention or treatment? 
Aim 2 results found that, in agreement with the original hypothesis, PRO measures 
were slightly better than PB measures at measuring significant differences between 
 30 
baseline and follow-up for both intervention arms of the WWE program. These results 
suggest that, perhaps, PRO measures may be marginally more useful than PB 
measures in assessing physical function and evaluating an intervention that attempts to 
improve the overall physical functioning of its participants. Further analysis found that 
none of the “differences in differences” of scores, among all the physical function 
measures, were significant over time for either intervention arm. This provides insight 
into the WWE study itself—the physical function measures were effective in measuring 
significant differences within each of the intervention arms respectively, but not when 
comparing one study arm to the other. Thus, perhaps Arm 1 and Arm 2, or the group 
and the independent formats of the study, were both equally effective in improving 
physical function of participants over time. 
 
• To what extent do PRO and PB measures associate with other patient-centered 
outcomes (fatigue, pain, stiffness) that have been shown to be associated with 
physical functioning? 
The results of the Spearman’s correlation calculations in Aim 3 showed that key arthritis 
outcomes—pain, fatigue, and stiffness—had a stronger negative correlation on average 
with PRO measures as opposed to PB measures. Additionally, these correlations for the 
PRO measures could be classified as “moderate”. However, interpreting the results of 
Aim 3 involves the important assumption that the VAS scale is reliable for measuring 
pain, fatigue, and stiffness. In other words, the comparatively stronger correlations 
between the PRO measures and VAS versus the PB measures and VAS are dependent 
on the knowledge that VAS measured the key arthritis outcomes in a valid way at 
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baseline and at follow-up. Furthermore, although this study questions and explores the 
validity and reliability of the measures of physical function, this particular research aim 
assumes also that both types of measures are valid as well.  
However, similar to the concerns in Aim 1, there are multiple sources of error 
present in measuring these arthritis outcomes through self-reports. One could even 
argue these outcomes are even more subjective than physical function. This raises the 
possibility of participants failing to remember or accurately describe the pain they were 
experiencing, for example, or incorrectly marking their pain intensity on the 100-mm line 
provided on the VAS response form. 
 
IMPLICATIONS  
This study promotes the importance of ascertaining the degree of similarity and 
overlap between an “objective” method of outcomes measurement (performance-based 
measures) and subjective (but still standardized) patient reports. The findings of this 
study suggest that: 
1. Patient-reported and performance-based measures may be measuring physical 
function differently from one another, but 
2. Both measures may be equally as effective in assessing an intervention centered 
on improving physical functioning, as both measures detect significant changes 
in physical functioning over time. Furthermore, 
3. Patient-reported measures may be more effective in measuring physical function 
in the context of its relationship with other patient-centered endpoints. 
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This information is important for researchers who are faced with the dilemma of 
wanting to choose a standardized outcome measure for evaluating the effectiveness of 
an intervention. The advantages of using only PRO measures to assess outcomes are 
manifold, and include the fact that they allow patients or participants, whom many feel 
know better than anyone else about their own symptoms or outcomes, to report a 
personalized perspective on a particular intervention or treatment. However, proponents 
of using objective, performance-based measures as the sole metric for measuring 
outcomes emphasize the element of standardization, which is important for maintaining 
consistency when measuring highly subjective outcomes (such as arthritis outcomes). 
For these reasons, perhaps researchers would benefit from incorporating both PRO and 
PB measures into interventions. This suggestion brings up new concerns, however; for 
example, if both measures produce different results, which measures should be viewed 
as the “primary” source that could be used to determine effectiveness of an 
intervention? Furthermore, there is a high likelihood that utilizing both measures in a 
given study could lead to a high administrative burden when needing to administer PRO 
surveys as well as PB tests, including greater expenditures of time and money. On a 
case-by-case basis, however, perhaps researchers can mitigate the barriers to using 
both types of outcomes measures and ensure that they incorporate standardized, 
performance-based metrics into their study to objectively measure outcomes but also 
benefit from the value-added that PRO measures provide in terms of subjectivity. 
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CONCLUSION 
The application of PRO measures to the Arthritis Foundation’s Walk With Ease (WWE) 
program in order to evaluate outcomes of the is just one example of the many diverse 
ways that patient self-reports can be used in incorporating the patient experience into 
clinical research as well as healthcare delivery. Patient-reported outcomes research has 
the potential to become the new frontier in comparative effectiveness research. This 
study examines the importance of using statistically sound measure scales to evaluate 
patient reported outcomes measures and hopefully provides support for their validity as 
a measurement tool in order to proliferate their use in clinical research and healthcare 
delivery. Ideally, in continuing to conduct this type of research, it will be possible to 
celebrate PROs as a “gold standard” of HRQOL research and to fully incorporate 
patient reports into the effort towards patient-centeredness in care delivery. 
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APPENDIX A 
 
Table 1. Baseline Demographic Characteristics of Arm 1 and Arm 2 Participants of 
WWE Program 
Continuous Variables Arm 1 - Group (N=192) 
Arm 2 - 
Independent 
(N=270) 
Total 
Participants 
(N=462) 
Age in years, MEAN 
(SDEV) 70.6 (9.9) 64.4 (11.8) 70.0 (11.5) 
BMI (kg/m2), MEAN (SDEV) 29.3(6.4) 30.1 (7.0) 29.7(6.8) 
Categorical Variables       
Gender (%)       
Male 14.6 (N=28) 10.4 (N=28) 12 (N=56) 
Female 85.4 (N=164) 89.6 (N=242) 88 (N=406) 
Marital Status (%)  
 
    
Married 47.4 (N=91) 55.2 (N=149) 51.9 (N=240) 
Separated/Divorced 11.5 (N=22) 14.4 (N=39) 13.2 (N=61) 
Living w/ Significant 
Other 1.6 (N=3) 0.37 (N=1) 0.87 (N=4) 
Widowed 31.3 (N=60) 16.7 (N=45) 22.7(N=105) 
Single 7.8 (N=15) 13 (N=35) 10.8 (N=50) 
Missing Data/Other 0.37 (N=1) 0.52 (N=1) 0.43 (N=2) 
Education (%)       
<High School 7.3 (N=14) 2.6 (N=7) 4.5 (N=21) 
High School 27.6 (N=53) 19.3 (N=52) 22.7 (N=105) 
>High School 65.1 (N=125) 78.1 (N=211) 72.7 (N=336) 
Race (%)       
White 70.3 (N=135) 70.3 (N=190) 70.3 (N=325) 
African-American 25.5 (N=49) 25.2 (N=68) 25.3 (N=117) 
Other 4.2 (N=8) 4.4 (N=12) 4.3 (N=20) 
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APPENDIX B 
 
Table 2. Baseline and Follow-up Spearman’s Correlations Between PRO and PB Physical 
Function Measures+ 
 Single 
Leg 
Stance- 
Right 
Leg 
Single 
Leg 
Stance- 
Left Leg 
2-
minute 
Step 
Test 
3 Chair 
Stands 
Normal 
Walk 
Fast 
Walk 
Turn 
Right 
Turn 
Left 
BASELINE  
HAQ Score -0.2125* -0.2635* -0.3493* 0.3966* -0.3616 -0.4141* 0.2973* 0.3187* 
PROMIS  
Physical 
Function 
Score 
0.2794* 0.2883* 0.3956* -0.4327* 0.3743* 0.4673* -0.3361* -0.3378* 
FOLLOW 
UP  
HAQ Score -0.3038* -0.2946* -0.2964* 0.3917* -0.3395* -0.3527* 0.2737* 0.2882* 
PROMIS 
Physical 
Function 
Score 
0.3656* 0.3187* 0.3802* -0.4311* 0.4215* 0.4599* -0.3559* -0.3703* 
 
+ = indicates statistical significance at an alpha level of 0.05. 
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APPENDIX C 
Table 3. Significance of Score Differences for each Physical Function Measure in Arm 1 
(Group) 
PROMIS	  
SCORE	  
	   	   	   	   	   	  
Ha:	  diff	  !=	  
0	  (Two-­‐
tailed)	  
Ha:	  diff	  >	  0	  
(One-­‐tailed)	  	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
PROMIS	  –	  
Follow	  Up	   173	   44.55491	   0.4696376	   6.177118	   43.62792	   45.48191	   2.3597	   0.0194	   0.0097	  
PROMIS	  -­‐	  
Baseline	   173	   43.80173	   0.4899929	   6.444851	   42.83456	   44.76891	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   173	   0.7531793	   0.3191891	   4.198277	   0.1231473	   1.383211	   	  	   	  	   	  	  
Single	  Leg	  
Stance	  -­‐	  
Right	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Single 
Leg Step 
Test- 
Right 
Leg–	  
Follow	  Up	   150	   14.02373	   0.9308619	   11.40068	   12.18434	   15.86313	   2.3209	   0.0216	   0.0108	  
Single 
Leg Step 
Test- 
Right 
Leg—
Baseline	  	   150	   12.15507	   0.8912397	   10.91541	   10.39397	   13.91617	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   150	   1.868667	   0.805154	   9.861083	   0.2776717	   3.459662	   	  	   	  	   	  	  
Single	  Leg	  
Stance	  -­‐	  
Left	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Single 
Leg Step 
Test- Left 
Leg—
Follow 
Up	   155	   13.59006	   0.953549	   11.87159	   11.70634	   15.47379	   1.7945	   0.0747	   0.0373	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Single	  Leg	  
Step	  Test-­‐
Left	  Leg—
Baseline	  	   155	   12.19723	   0.9034004	   11.24724	   10.41257	   13.98188	   	  	   	  	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   155	   1.392839	   0.7761517	   9.66301	  
-­‐
0.1404397	   2.926117	   	  	   	  	   	  	  
Two	  
Minute	  
Step	  Test	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
2-­‐Minute	  
Step	  
Test—
Follow	  Up	   148	   73.40541	   2.198167	   26.74186	   69.06131	   77.7495	   -­‐0.8744	   0.3833	   0.8083	  
2-­‐Minute	  
Step	  
Test—
Baseline	  	   148	   74.96622	   1.949147	   23.7124	   71.11425	   78.81819	   	  	   	  	   	  	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   148	   -­‐1.560811	   1.785012	   21.71561	   -­‐5.088411	   1.96679	   	  	   	  	   	  	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
HAQ	  
SCORE	  
	   	   	   	   	   	   	  
Ha:	  diff	  !=	  0	  
(two-­‐tailed)	  
Ha:	  diff	  <	  0	  
(one-­‐tailed)	  	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
HAQ	  
Score—
Follow	  Up	   221	   10.69702	   0.7940376	   11.80422	   9.132131	   12.26192	   -­‐5.2019	   0.0000	   0.0000	  
HAQ	  
Score—
Baseline	  	   221	   13.67535	   0.862763	   12.82589	   11.97501	   15.37568	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   221	   -­‐2.978322	   0.5725473	   8.511528	   -­‐4.106701	   -­‐1.849942	   	  	   	  	   	  	  
Chair	  
Stand	  3	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
3	  Chair	  
Stands—
Follow	  Up	  	   156	   8.317949	   0.1840877	   2.299255	   7.954304	   8.681593	   -­‐5.2316	   0.0000	   0.0000	  
3	  Chair	  
Stands— 156	   9.587821	   0.301437	   3.764947	   8.992366	   10.18328	   	  	   significant	   significant	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Baseline	  	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   156	   -­‐1.269872	   0.2427307	   3.031706	   -­‐1.749359	  
-­‐
0.7903847	   	  	   	  	   	  	  
Normal	  
Walk	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Normal	  
Walk—
Follow	  Up	   163	   1.170725	   0.0181453	   0.2316637	   1.134893	   1.206557	   3.9131	   0.0001	   0.0001	  
Normal	  
Walk—
Baseline	  	   163	   1.123007	   0.0171308	   0.2187112	   1.089179	   1.156835	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   163	   0.0477181	   0.0121943	   0.1556867	   0.0236378	   0.0717984	   	  	   	  	   	  	  
Fast	  Walk	  
	   	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Fast	  
Walk—
Follow	  Up	  	   162	   1.575313	   0.0263947	   0.33595	   1.523189	   1.627438	   2.3126	   0.0220	   0.1101	  
Fast	  
Walk—
Baseline	  	   162	   1.537001	   0.0246118	   0.3132577	   1.488397	   1.585604	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   162	   0.0383129	   0.016567	   0.210863	   0.0055963	   0.0710295	   	  	   	  	   	  	  
Turn	  Left	  
	   	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Turn	  
Left—
Follow	  Up	   163	   2.800276	   0.0725317	   0.9260228	   2.657047	   2.943506	   -­‐4.4063	   0.0000	   0.0000	  
Turn	  
Left—
Baseline	  	   163	   3.137638	   0.1143963	   1.460514	   2.911738	   3.363538	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   163	   -­‐0.337362	   0.076563	   0.9774911	  
-­‐
0.4885522	  
-­‐
0.1861718	   	  	   	  	   	  	  
Turn	  Right	  
	   	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	  
[95%	  
Conf.	   Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	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Turn	  
Right—
Follow	  Up	   163	   2.859693	   0.0787061	   1.004852	   2.704271	   3.015115	   -­‐3.9433	   0.0001	   0.0001	  
Turn	  
Right—
Baseline	  	   163	   3.157699	   0.1098993	   1.4031	   2.94068	   3.374719	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   163	   -­‐0.2980061	   0.0755721	   0.9648398	  
-­‐
0.4472395	  
-­‐
0.1487727	   	  	   	  	   	  	  
 
 
Table 4. Significance of Score Differences for each Physical Function Measure in Arm 2 
(Independent) 
PROMIS	  SCORE	  
	   	   	   	   	   	  
Ha:	  diff	  !=	  0	  
(two-­‐tailed)	  
Ha:	  diff	  >	  0	  
(one-­‐tailed)	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
PROMIS	  –	  
Follow	  Up	   154	   43.70974	   0.5569432	   6.911483	   42.60945	   44.81003	   2.9790	   0.0034	   0.0017	  
PROMIS	  -­‐	  
Baseline	   154	   42.57143	   0.5177404	   6.424989	   41.54859	   43.59427	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   154	   1.138312	   0.3821168	   4.741945	   0.3834056	   1.893218	   	  	   	  	   	  	  
Single	  Leg	  Stance	  
-­‐	  Right	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Single 
Leg Step 
Test- 
Right 
Leg–	  
Follow	  Up	   126	   11.36151	   0.9970573	   11.19194	   9.388208	   13.33481	   3.3974	   0.0009	   0.0005	  
Single 
Leg Step 
Test- 
Right 
Leg—
Baseline	  	   126	   8.578651	   0.8069739	   9.058259	   6.981549	   10.17575	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   126	   2.782857	   0.8191169	   9.194564	   1.161723	   4.403991	   	  	   	  	   	  	  
	  
Single	  Leg	  Stance	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-­‐	  Left	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Single 
Leg Step 
Test- Left 
Leg—
Follow 
Up	   131	   10.82901	   0.9614084	   11.00382	   8.926976	   12.73104	   3.0782	   0.0025	   0.0013	  
Single	  Leg	  
Step	  Test-­‐
Left	  Leg—
Baseline	  	   131	   8.340992	   0.7997444	   9.153492	   6.758794	   9.923191	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   131	   2.488015	   0.8082584	   9.25094	   0.8889727	   4.087058	   	  	   	  	   	  	  
Two	  Minute	  Step	  
Test	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
2-­‐Minute	  
Step	  
Test—
Follow	  Up	   138	   74.05072	   2.266151	   26.62125	   69.56957	   78.53188	   -­‐0.8152	   0.4164	   0.7918	  
2-­‐Minute	  
Step	  
Test—
Baseline	  	   138	   75.5942	   1.974813	   23.1988	   71.68915	   79.49926	   	  	   	  	   	  	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   138	   -­‐1.543478	   1.893441	   22.24289	   -­‐5.287627	   2.200671	   	  	   	  	   	  	  
HAQ	  
SCORE	  
	   	   	   	   	   	   	  
Ha:	  diff	  !=	  0	  
(two-­‐tailed)	  
Ha:	  diff	  <	  0	  
(one-­‐tailed)	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
HAQ	  
Score—
Follow	  Up	   173	   13.51887	   1.104021	   14.52113	   11.33969	   15.69804	   -­‐3.3574	   0.0010	   0.0005	  
HAQ	  
Score—
Baseline	  	   173	   15.77878	   1.101377	   14.48635	   13.60482	   17.95273	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   173	   -­‐2.259908	   0.6731183	   8.853489	   -­‐3.588544	  
-­‐
0.9312725	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3	  Chair	  Stands	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
3	  Chair	  
Stands—
Follow	  Up	  	   145	   9.332179	   0.288547	   3.474566	   8.761845	   9.902514	   -­‐5.0972	   0.0000	   0.0000	  
3	  Chair	  
Stands—
Baseline	  	   145	   10.35028	   0.2879965	   3.467937	   9.781029	   10.91952	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   145	   -­‐1.018097	   0.1997356	   2.405135	   -­‐1.412889	  
-­‐
0.6233041	   	  	   	  	   	  	  
Normal	  Walk	  
	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Normal	  
Walk—
Follow	  Up	   145	   1.122702	   0.0197116	   0.2373593	   1.08374	   1.161663	   4.1056	   0.0001	   0.0000	  
Normal	  
Walk—
Baseline	  	   145	   1.058678	   0.016457	   0.198169	   1.026149	   1.091206	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   145	   0.0640241	   0.0155942	   0.187779	   0.033201	   0.0948472	   	  	   	  	   	  	  
Fast	  Walk	  
	   	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Fast	  
Walk—
Follow	  Up	  	   145	   1.513392	   0.0296645	   0.3572083	   1.454758	   1.572026	   4.1785	   0.0001	   0.0000	  
Fast	  
Walk—
Baseline	  	   145	   1.435168	   0.0265106	   0.3192304	   1.382768	   1.487568	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   145	   0.0782239	   0.0187205	   0.2254245	   0.0412214	   0.1152263	   	  	   	  	   	  	  
Turn	  Left	  
	   	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Turn	  
Left—
Follow	  Up	   143	   3.252276	   0.0953571	   1.140305	   3.063773	   3.440779	   -­‐5.7658	   0.0000	   0.0000	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Turn	  
Left—
Baseline	  	   143	   3.684825	   0.0988314	   1.181852	   3.489454	   3.880196	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   143	   -­‐0.4325489	   0.0750192	   0.8970993	  
-­‐
0.5808477	  
-­‐
0.2842502	   	  	   	  	   	  	  
Turn	  Right	  
	   	   	   	   	   	   	   	   	  
Measure	   Obs	   Mean	   Std.	  Err.	   Std.	  Dev.	   [95%	  Conf.	  Interval]	  
Test	  
statistic	  
(T)	   P-­‐Value	   P-­‐Value	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Turn	  
Right—
Follow	  Up	   143	   3.294427	   0.0978211	   1.169771	   3.101053	   3.4878	   -­‐5.1017	   0.0000	   0.0000	  
Turn	  
Right—
Baseline	  	   143	   3.725979	   0.1015543	   1.214413	   3.525225	   3.926733	   	  	   significant	   significant	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
diff	   143	   -­‐0.4315524	   0.0845905	   1.011556	   -­‐0.598772	  
-­‐
0.2643329	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Table 5. T-test results and Statistical Significance of Score Differences Stratified by Study 
Arm 
DIFFERENCE 
IN HAQ 
SCORE 
      
Ha: diff != 0 
(Two-tailed) 
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 221 -2.9783 0.5725 -4.1067 -1.8499 -0.8169 0.4145 
2 173 -2.2599 0.6731 -3.5885 -0.9313   not significant 
                
combined 394 -2.6629 0.4363 -3.5206 -1.8052     
                
diff   -0.7184 0.8794 -2.4474 1.0106     
DIFFERENCE IN 
PROMIS SCORE 
     
  
Study Arm Obs Mean 
Std. 
Err. 
[95% Conf. Interval] 
 
Test 
statistic (T) P-Value 
                
1 173 0.7532 0.3192 0.1231 1.3832 -0.7790 0.4365 
2 154 1.1383 0.3821 0.3834 1.8932   not significant 
                
combined 327 0.9346 0.2466 0.4494 1.4197     
                
diff   -0.3851 0.4944 -1.3577 0.5875     
DIFFERENCE IN 
Single Leg Stance - 
Right 
     
  
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 150 1.8687 0.8052 0.2777 3.4597 -0.7911 0.4296 
2 126 2.7829 0.8191 1.1617 4.4040   not significant 
                
combined 276 2.2860 0.5752 1.1536 3.4184     
                
diff   -0.9142 1.1556 -3.1892 1.3608     
DIFFERENCE IN 
Single Leg Stance - 
Left 
     
  
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 155 1.3928 0.7762 -0.1404 2.9261 -0.9738 0.3310 
2 131 2.4880 0.8083 0.8890 4.0871   not significant 
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combined 286 1.8945 0.5603 0.7916 2.9974     
                
diff   -1.0952 1.1247 -3.3090 1.1186     
DIFFERENCE IN Two 
Minute Step Test 
     
  
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 148 -1.5608 1.7850 -5.0884 1.9668 -0.0067 0.9947 
2 138 -1.5435 1.8934 -5.2876 2.2007   not significant 
                
combined 286 -1.5524 1.2969 -4.1052 1.0003     
                
diff   -0.0173 2.6000 -5.1350 5.1004     
DIFFERENCE IN Chair 
Stand 3 
     
  
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 156 -1.2699 0.2427 -1.7494 -0.7904 -0.7943 0.4277 
2 145 -1.0181 0.1997 -1.4129 -0.6233   not significant 
                
combined 301 -1.1486 0.1583 -1.4601 -0.8371     
                
diff   -0.2518 0.3170 -0.8756 0.3720     
DIFFERENCE IN 
Normal Walk 
     
  
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 163 0.0477 0.0122 0.0236 0.0718 -0.8327 0.4057 
2 145 0.0640 0.0156 0.0332 0.0948   not significant 
                
combined 308 0.0554 0.0098 0.0362 0.0746     
                
diff   -0.0163 0.0196 -0.0548 0.0222     
DIFFERENCE 
IN Fast Walk 
      
  
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 162 0.0383 0.0166 0.0056 0.0710 -1.6025 0.1101 
2 145 0.0782 0.0187 0.0412 0.1152   not significant 
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combined 307 0.0572 0.0125 0.0326 0.0817     
                
diff   -0.0399 0.0249 -0.0889 0.0091     
DIFFERENCE 
IN Turn Left 
      
  
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 163 -0.3374 0.0766 -0.4886 -0.1862 0.8830 0.3779 
2 143 -0.4325 0.0750 -0.5808 -0.2843   not significant 
                
combined 306 -0.3818 0.0538 -0.4876 -0.2761     
                
diff   0.0952 0.1078 -0.1169 0.3073     
DIFFERENCE 
IN Turn Right 
      
  
Study Arm Obs Mean 
Std. 
Err. [95% Conf. Interval] 
Test 
statistic (T) P-Value 
                
1 163 -0.2980 0.0756 -0.4472 -0.1488 1.1810 0.2385 
2 143 -0.4316 0.0846 -0.5988 -0.2643   not significant 
                
combined 306 -0.3604 0.0565 -0.4715 -0.2493     
                
diff   0.1335 0.1131 -0.0890 0.3561     
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Table 6. Baseline and Follow-up Spearman’s Correlations between VAS and PB and PRO 
Measures of Physical Function 
 
HAQ 
Score 
PROMIS 
Physica
l 
Functio
n Score 
Single 
Leg 
Step 
Test- 
Right 
Leg 
Single 
Leg 
Step 
Test- 
Left 
Leg 
2-
minute 
Step 
Test 
3 Chair 
Stands 
Normal 
Walk 
Fast 
Walk 
Turn  
Right 
Turn  
Left 
BASELINE  
VAS - 
Pain 
0.4216
* -0.3418* -0.0043 -0.0103 -0.2056* 0.1682* -0.1152* 
-
0.1725* 0.0145 0.0169 
VAS - 
Fatigue 
0.4034
* -0.3233* 0.0184 -0.0025 -0.2351* 0.2308* -0.1130* 
-
0.1018* 0.0495 0.0423 
VAS - 
Stiffness 
0.4010
* -0.3667* -0.0301 -0.0521 -0.2172* 0.1916* -0.1051* 
-
0.1530* 0.1163* 0.0962 
FOLLOW 
UP 
          VAS - 
Pain 
0.4014
* -0.4209* -0.1021 
-
0.1717* -0.2111* 0.2455* -0.1816* 
-
0.1641* 0.1304* 0.1593* 
VAS - 
Fatigue 
0.3090
* -0.3375* -0.0898 -0.1202 -0.1515* 0.1794* -0.1366* 
-
0.1363* 0.0725 0.1261* 
VAS - 
Stiffness 
0.2673
* -0.2398* -0.0913 
-
0.1443* -0.1034 0.1784* -0.1108 -0.0989 
0.0335
5 0.0744 
 + = indicates statistical significance at an alpha level of 0.05. 
 
 
 
 
 
 
